ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 58 filers reported holding ANNOVIS BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $147,000 | -8.7% | 14,210 | 0.0% | 0.09% | -6.5% |
Q2 2022 | $161,000 | -15.3% | 14,210 | 0.0% | 0.09% | -22.7% |
Q1 2022 | $190,000 | -24.0% | 14,210 | 0.0% | 0.12% | -13.1% |
Q4 2021 | $250,000 | -44.6% | 14,210 | 0.0% | 0.14% | -39.1% |
Q3 2021 | $451,000 | -86.6% | 14,210 | -63.8% | 0.22% | -87.2% |
Q2 2021 | $3,356,000 | – | 39,210 | – | 1.75% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynwood Capital Management Inc. | 12,500 | $142,000 | 0.16% |
Wescott Financial Advisory Group, LLC | 41,607 | $472,000 | 0.13% |
Sterling Investment Advisors, Ltd. | 26,974 | $306,000 | 0.10% |
Knoll Capital Management, LLC | 14,210 | $161,000 | 0.09% |
Essex LLC | 10,408 | $118,000 | 0.04% |
FNY Investment Advisers, LLC | 3,650 | $41,000 | 0.03% |
Modera Wealth Management, LLC | 30,913 | $351,000 | 0.02% |
Koshinski Asset Management, Inc. | 10,000 | $113,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 23,600 | $268,000 | 0.01% |
Cannell & Co. | 10,000 | $113,000 | 0.00% |